| Name | Title | Contact Details |
|---|
NY CREATES is a world leading R&D, innovation hub and commercialization facilitator that works with researchers in industry, academia and national labs to leverage the state of the art infrastructure in upstate New York and to partner with NY CREATES’ ...
Lenox Hill Hospital, a member of the North Shore-LIJ Health System, is a 652-bed, fully accredited, acute care hospital located on Manhattan’s Upper East Side with a national reputation for outstanding patient care and innovative medical and surgical treatments. US News and World Report has ranked the hospital among the nation’s top 50 in Cardiology and Heart Surgery and among the top 10 hospitals in the state of New York with a total of 11 “high performing” designations for its clinical performance in Cancer, Diabetes and Endocrinology, Ear, Nose and Throat, Gastroenterology and GI Surgery, Geriatrics, Gynecology, Nephrology, Neurology and Neurosurgery, Orthopedics, Pulmonology and Urology.
Vetoquinol N.-A. Inc is a Lavaltrie, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Alternate Health (CSE: AHG, OTCQB: AHGIF) an international leader in the hemp-derived CBD industry, including extraction, product development and distribution. Alternate Health`s industry-leading software systems provide the platform for the company`s diverse operations, including blockchain tax collection systems, hemp-derived CBD product distribution, extract manufacturing and patient management systems for specialty clinics across North America. Through Alternate Health`s subsidiary, Blaine Labs, the Company is a leader in cGMP medical product manufacturing and distribution, with over 50 product SKUs available from major retailers, including Walmart, Amazon, CVS and Walgreens. Alternate Health`s corporate office is located in Toronto, Canada, with additional offices in Venice, California, and San Antonio, Texas. The Company is well positioned to reinvest internal operating cash flow in its platform and product development over the long term, creating an attractive investment profile for its shareholders.
Columbia Laboratories is a specialty pharmaceutical company that develops and commercializes innovative products for women’s healthcare and endocrine-related conditions. Our FDA-approved products include formulations that treat infertility, menstrual irregularities and hormonal deficiencies. Columbia’s products utilize our proprietary Bioadhesive Delivery System (BDS), which leverages the principle of bioadhesion to administer medication. This technology can deliver many types of compounds, including hormones and peptides, providing numerous internal and licensing product development opportunities.